Guido J. Neels
CIK: 0001222362
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jun 11, 2026ELUT
ELUTIA INC.
Award(A)DirectStock Option (Right to Buy)
106.4K shares- - Jun 9, 2026TELA
TELA Bio, Inc.
Award(A)Direct11.9K shares- - Jun 9, 2026TELA
TELA Bio, Inc.
Award(A)Direct11.7K shares- - Jun 3, 2026BVS
Bioventus Inc.
Award(A)DirectRestricted Stock Units
25.1K shares- - Jun 2, 2026BVS
Bioventus Inc.
Exercise(M)Direct32.3K shares- - Jan 30, 2026ELUT
ELUTIA INC.
Purchase(P)Direct20K shares at avg. $1.04$21K - Jan 29, 2026ELUT
ELUTIA INC.
Purchase(P)Direct15K shares at avg. $1.06$16K - Jan 28, 2026ELUT
ELUTIA INC.
Purchase(P)Direct15K shares at avg. $1.06$16K - Dec 10, 2025ELUT
ELUTIA INC.
Exercise(M)Direct6.3K shares- - Dec 1, 2025ELUT
ELUTIA INC.
Exercise(M)Direct6.3K shares- - Oct 9, 2025ELUT
ELUTIA INC.
Award(A)DirectStock Option (Right to Buy)
171.9K shares- - Jun 9, 2025AXGN
Axogen, Inc.
Sale(S)Direct4.1K shares at avg. $10.61$43K - Jun 3, 2025BVS
Bioventus Inc.
Award(A)DirectRestricted Stock Units
32.3K shares- - Jun 2, 2025BVS
Bioventus Inc.
Exercise(M)Direct26.5K shares- - Sep 1, 2024AXGN
Axogen, Inc.
Exercise(M)Direct11.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  ELUT ELUTIA INC. | Award(A) Stock Option (Right to Buy) | 106,393 | - | - | Direct |
| Jun 9, 2026 |  TELA TELA Bio, Inc. | Award(A) | 11,925 | - | $0 | Direct |
| Jun 9, 2026 | TELA TELA Bio, Inc. | Award(A) | 11,675 | - | $0 | Direct |
| Jun 3, 2026 |  BVS Bioventus Inc. | Award(A) Restricted Stock Units | 25,146 | - | - | Direct |
| Jun 2, 2026 | BVS Bioventus Inc. | Exercise(M) | 32,282 | - | $0 | Direct |
| Jan 30, 2026 | ELUT ELUTIA INC. | Purchase(P) | 20,000 | $1.04 | $20,800 | Direct |
| Jan 29, 2026 | ELUT ELUTIA INC. | Purchase(P) | 15,000 | $1.06 | $15,900 | Direct |
| Jan 28, 2026 | ELUT ELUTIA INC. | Purchase(P) | 15,000 | $1.06 | $15,900 | Direct |
| Dec 10, 2025 | ELUT ELUTIA INC. | Exercise(M) | 6,250 | - | $0 | Direct |
| Dec 1, 2025 | ELUT ELUTIA INC. | Exercise(M) | 6,250 | - | - | Direct |
| Oct 9, 2025 | ELUT ELUTIA INC. | Award(A) Stock Option (Right to Buy) | 171,916 | - | - | Direct |
| Jun 9, 2025 |  AXGN Axogen, Inc. | Sale(S) | 4,073 | $10.61 | $43,215 | Direct |
| Jun 3, 2025 | BVS Bioventus Inc. | Award(A) Restricted Stock Units | 32,282 | - | - | Direct |
| Jun 2, 2025 | BVS Bioventus Inc. | Exercise(M) | 26,493 | - | - | Direct |
| Sep 1, 2024 | AXGN Axogen, Inc. | Exercise(M) | 11,904 | - | $0 | Direct |
1-15 of 15 transactions
About NEELS GUIDO J
NEELS GUIDO J (SEC CIK 0001222362) files insider reports with the SEC as Director of ELUTIA INC. (ELUT), Director of TELA Bio, Inc. (TELA) and Director of Bioventus Inc. (BVS). Signal8 also holds filings tied to 1 other company.
Signal8 holds 13 ownership filings by NEELS GUIDO J (2 Form 3, 11 Form 4), filed between Sep 4, 2024 and Jun 15, 2026. Those filings report 15 transactions, from Sep 1, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on NEELS GUIDO J's filings is in DURHAM, NC.
Recent filings by NEELS GUIDO J
- Jun 11, 2026: Grant or award of ELUT derivative securities (Form 4, code A).
- Jun 9, 2026: Grants or awards of TELA shares (2 lines, Form 4, code A).
- Jun 3, 2026: Grant or award of BVS derivative securities (Form 4, code A).
- Jun 2, 2026: Option exercise of BVS shares (Form 4, code M).
- Jan 30, 2026: Open-market purchase of ELUT shares (Form 4, code P).
Other insiders filing for ELUTIA INC. (ELUT)
- Williams Michelle LeRoux, CHIEF SCIENTIFIC OFFICER
- Ferguson Matthew, CHIEF FINANCIAL OFFICER
- Mills C Randal, PRESIDENT AND CEO
- RAKIN KEVIN, Director
- Colpman David, Director
- Makes Brigid, Director